Roth Capital Issues Negative Estimate for Vitalhub Earnings

Vitalhub Corp. (TSE:VHI) – Analysts at Roth Capital cut their Q1 2026 EPS estimates for Vitalhub in a research report issued on Monday, November 10th. Roth Capital analyst R. Baldry now anticipates that the company will post earnings of $0.05 per share for the quarter, down from their prior estimate of $0.06. The consensus estimate for Vitalhub’s current full-year earnings is $0.23 per share. Roth Capital also issued estimates for Vitalhub’s Q2 2026 earnings at $0.05 EPS, Q3 2026 earnings at $0.05 EPS, Q4 2026 earnings at $0.07 EPS and FY2026 earnings at $0.22 EPS.

Vitalhub (TSE:VHI) last issued its quarterly earnings data on Thursday, November 6th. The company reported C($0.01) EPS for the quarter. The company had revenue of C$32.04 million for the quarter. Vitalhub had a return on equity of 3.01% and a net margin of 5.11%.

A number of other equities research analysts have also issued reports on the company. TD Securities lifted their target price on Vitalhub from C$15.00 to C$16.00 and gave the company a “buy” rating in a research report on Monday, August 11th. Stifel Nicolaus set a C$15.00 price target on shares of Vitalhub and gave the stock a “buy” rating in a research note on Wednesday, October 15th. Stifel Canada upgraded shares of Vitalhub to a “strong-buy” rating in a report on Tuesday, October 14th. National Bankshares set a C$16.00 target price on shares of Vitalhub and gave the stock an “outperform” rating in a report on Thursday, August 21st. Finally, Royal Bank Of Canada set a C$15.00 target price on shares of Vitalhub and gave the company a “moderate buy” rating in a research report on Thursday, September 18th. Two equities research analysts have rated the stock with a Strong Buy rating and seven have assigned a Buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of C$14.86.

Vitalhub Price Performance

Shares of VHI traded down C$0.21 during midday trading on Thursday, hitting C$9.59. The stock had a trading volume of 83,224 shares, compared to its average volume of 159,668. The firm has a market cap of C$602.54 million, a price-to-earnings ratio of 119.88, a price-to-earnings-growth ratio of 1.18 and a beta of 0.70. The company has a 50 day simple moving average of C$10.91 and a two-hundred day simple moving average of C$11.45. Vitalhub has a twelve month low of C$8.50 and a twelve month high of C$14.64.

Insider Activity at Vitalhub

In other Vitalhub news, Director Danny Matlow sold 150,000 shares of the firm’s stock in a transaction on Thursday, August 28th. The stock was sold at an average price of C$12.75, for a total transaction of C$1,912,500.00. Following the completion of the sale, the director owned 520,001 shares of the company’s stock, valued at C$6,630,012.75. This trade represents a 22.39% decrease in their position. Also, Director Steve Garrington sold 20,000 shares of Vitalhub stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of C$12.90, for a total transaction of C$258,000.00. Following the transaction, the director directly owned 60,000 shares of the company’s stock, valued at approximately C$774,000. This trade represents a 25.00% decrease in their ownership of the stock. Insiders own 18.57% of the company’s stock.

Vitalhub Company Profile

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.